ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.38
0.89%
US Tech 100
18,514.00
1.00%
S&P 500
5,459.10
1.11%
US Dollar vs CAD
1.38295
0.00%
Bitcoin
68,177.12
0.39%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Quest Diagnostics Inc (DGX)

  7. Quest Diagnostics Inc (DGX) News

DGX

Quest Diagnostics (DGX)

Quest Diagnostics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:DGX
DateTimeSourceHeadlineSymbolCompany
07/26/20245:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
07/26/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
07/26/20245:32PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
07/26/20245:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
07/26/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
07/25/20245:45AMPR Newswire (US)BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other DiseasesNYSE:DGXQuest Diagnostics Inc
07/24/20244:31PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:DGXQuest Diagnostics Inc
07/24/20243:44PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:DGXQuest Diagnostics Inc
07/23/20245:46AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:DGXQuest Diagnostics Inc
07/23/20245:45AMPR Newswire (US)Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024NYSE:DGXQuest Diagnostics Inc
07/18/20243:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
07/18/20247:00AMGlobeNewswire Inc.Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer TherapyNYSE:DGXQuest Diagnostics Inc
07/10/20247:58AMPR Newswire (US)Quest Diagnostics to Acquire Outreach Laboratory Services of OhioHealthNYSE:DGXQuest Diagnostics Inc
07/03/20247:45AMPR Newswire (US)Quest Diagnostics to Acquire LifeLabs from OMERS, Enhancing Diagnostic Services for CanadiansNYSE:DGXQuest Diagnostics Inc
07/03/20247:45AMPR Newswire (Canada)Quest Diagnostics to Acquire LifeLabs from OMERS, Enhancing Diagnostic Services for CanadiansNYSE:DGXQuest Diagnostics Inc
06/27/20245:45AMPR Newswire (US)Quest Diagnostics Releases 2023 Corporate Responsibility ReportNYSE:DGXQuest Diagnostics Inc
06/26/20243:03PMPR Newswire (US)Quest Diagnostics to Acquire Select Lab Assets from Allina HealthNYSE:DGXQuest Diagnostics Inc
06/19/20242:00PMPR Newswire (US)Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024NYSE:DGXQuest Diagnostics Inc
06/11/20246:57AMPR Newswire (US)Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics' Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer DiagnosisNYSE:DGXQuest Diagnostics Inc
05/31/20243:08PMPR Newswire (US)Blood-based MRD Test for Cancer Recurrence Can Generate Cost Savings in Colorectal Cancer Treatment, Finds Study in JAMA Health ForumNYSE:DGXQuest Diagnostics Inc
05/21/20243:29PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:DGXQuest Diagnostics Inc
05/21/20248:19AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:DGXQuest Diagnostics Inc
05/20/20246:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
05/20/20246:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
05/20/20246:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
05/20/20246:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
05/20/20246:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
05/20/20246:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
05/20/20246:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
05/20/20246:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:DGXQuest Diagnostics Inc
 Showing the most relevant articles for your search:NYSE:DGX

Your Recent History

NASDAQ
RNAZ
TransCode Therapeutics
USOTC
BLLB
Bell Buckle (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
RDGL
Vivos (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
CEOS
CeCors (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
IJJP
IJJ (PK)
USOTC
ECSL
Ecare Solutions (PK)
NASDAQ
NVDA
NVIDIA
USOTC
BMXI
Brookmount Explorations (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
TPTW
TPT Global Tech (PK)
COIN
BTCUSD
Bitcoin
USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved